We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Rectangle Image
Article

Stay Up-to-Date With COVID-19 Vaccine Development

Rectangle Image
Article

Stay Up-to-Date With COVID-19 Vaccine Development

Read time:
 

Science is facing, arguably, one of its greatest challenges yet – the COVID-19 outbreakScientists across the globe are working tirelessly to understand the virus at a molecular level; how it survives, mutates, spreads and infects humans. Collectively, these efforts enhance our ability to develop both preventive and therapeutic strategies against SARS-CoV-2. Vaccines are an example of one such preventive.

Technology Networks is committed to keeping you updated with the latest research in this space. Below, you'll find a curation of our latest COVID-19 vaccine-related content. 

Latest COVID-19 vaccine video interviews:





Latest COVID-19 vaccine infographics:


The global response to the COVID-19 pandemic has included the development and authorization of a growing number of vaccines. How do they compare?

Download this infographic to find out more. 

Accelerate your efforts to combat infectious disease

Advertisement

Addressing the threat of new and potentially life-threatening pathogens requires deep understanding and accurate, reproducible techniques for developing better tests, vaccines, and treatments. Agilent provides the complete breadth of systems, consumables, software, services, and knowledge you need to support your success.

Learn more!

Latest COVID-19 vaccine news and article coverage:

Building Better Vaccines for SARS-CoV-2

- FDA Approves Pfizer COVID-19 Vaccine

Vaccine Efficacy Against Different SARS-CoV-2 Variants


Cross-Neutralizing Activity Found in Pfizer Jab Recipients That Had 2003 SARS

Early COVID-19 Vaccine Campaign in the US Prevented Nearly 140,000 Deaths

Developing Better Intranasal Vaccines for COVID-19 and Flu

Delta Variant Unable To Evade Antibodies Induced by COVID-19 Vaccination

Pregnant Women Tolerate COVID-19 Vaccines Well

Meet the Scientist Couple Driving an mRNA Vaccine Revolution

Simple Addition to COVID-19 Vaccines Could Enhance Their Effectiveness

Intranasal COVID-19 Vaccine Reduces Disease Severity and Blocks Transmission

New Light on Rare Cases of Blood Clotting Following COVID-19 Vaccination

Ideas for a Pan-Coronavirus Vaccine

Flu Shot Protects Against Severe Effects of COVID-19

16 and 17-Year-Olds To Receive First Dose of Pfizer Vaccine in the UK

UK Administers Over 85 Million COVID-19 Vaccines

One Billion Doses of Oxford COVID-19 Vaccine Have Been Released

Study Will Test Different Time Intervals for COVID-19 Vaccines in Pregnant Individuals

To Avoid Vaccine Hesitance, Emphasize Personal Health Benefits of COVID-19 Vaccination

Vaccine Antibody Levels Start To Decline After 2–3 Months

Developing Thermostable Vaccines To Improve Accessibility Worldwide

mRNA COVID-19 Vaccines: Safety of Second Dose Following First-Dose Allergic Reactions

Advantages of Intranasal Delivery of COVID-19 Vaccines

Pfizer COVID-19 Vaccine 78% Effective in Pregnant Women

Vaccine Passports Raise Equity Concerns

mRNA From COVID-19 Vaccine Is Not Transferred Through Mother’s Breast Milk

Are Biomaterial Vaccines on the Horizon?

mRNA Vaccine Recipients Are 91% Less Likely To Develop COVID-19

A Vaccine for All Coronaviruses

mRNA COVID-19 Vaccines Prime T Cells To Fight Against SARS-CoV-2 Variants

mRNA COVID-19 Vaccines Generate Germinal Centers Important for Lasting Immunity

- Study of COVID-19 Vaccination During Pregnancy and Postpartum Begins

COVID-19 Vaccines Pre-Prepared in Syringes Can Be Safely Transported

CureVac's COVID-19 Vaccine Demonstrates Interim Efficacy of 47%

COVID-19: Vaccines, Pregnancy, Menstruation, Breastfeeding and Fertility

Novavax COVID-19 Vaccine Demonstrates an Overall Efficacy of 90.4%

Addressing Racial Disparities in COVID-19 Vaccination

Janssen COVID-19 Vaccine Generates Immune Response Against Variants

Examining Risk–Benefit Profiles for Vaccines

COVID-19 Vaccine Safety in Pregnancy

UK Authorizes Pfizer COVID-19 Vaccine for 12 to 15-Year-Olds, but They May Not Be Offered It

Changing Up the Route of Vaccine Administration

Why mRNA Vaccines Could Be a Game Changer

COVID-19 Vaccine and Periods

Blood Test Confirms mRNA Vaccine Activates Robust Immune Response

Moderna’s COVID-19 Vaccine Is Safe and Effective in Adolescents

- The Ethics and Safety of COVID-19 Vaccine Passports


A Link Between Reduced Leptin Levels and Vaccine Response

Delaying Second Dose of Pfizer COVID-19 Vaccine Increases Antibody Response in the Elderly

- COVID-19 Vaccine Storage and Stability

A New Way of Predicting COVID-19 Vaccine Efficacy

Delaying Second COVID-19 Vaccine Dose May Prevent Deaths, Under Certain Conditions

Unintended Consequences: The Risks of Vacating COVID-19 Vaccine Patents

Mixing COVID-19 Vaccines Increases Side Effects, Preliminary Data Suggests

Study Finds COVID-19 Vaccines Do Not Damage the Placenta in Pregnancy

Toxicity Studies in Vaccine Clinical Development and Registration

Pan-Coronavirus Vaccine Blocks SARS-CoV-2 and Variants in Animal Study

The “Key” to COVID-19 Vaccine Development Lies in the Way the Virus Binds to Human Cells

COVID-19 Vaccine Prioritization and the Impact of Non-Pharmaceutical Interventions

Vaccine Production: Navigating Scale-Up Challenges

What the COVID-19 Pandemic Taught Us About Flexibility in Vaccine Manufacturing

UK Administers 50 Million Doses of COVID-19 Vaccine


Single Dose of COVID-19 Vaccine Boosts Protection Against Variants, but Only in Those With Prior Infection

Modeling Study Shows High Vaccination Rate Is Key to Course of COVID-19 Pandemic

One in Four People Experience Mild Side Effects From COVID-19 Vaccines

UK’s Preference for AstraZeneca COVID-19 Vaccine Has Declined, but Vaccine Confidence Levels Are Up

Moderna Announces Agreement with Sanofi for Fill/Finish Manufacturing of COVID-19 Vaccine

COVID-19 Vaccine Effectiveness Confirmed in Specific Sub-Populations

Why COVID-19 Vaccine Side Effects May Feel Worse After the Second Dose

Second COVID-19 Vaccine Important for Those Who Have Not Had the Disease

UK Government-Funded COVID-19 Vaccine Phase I/II Trials Report Positive Data

Denmark To Suspend Rollout of AstraZeneca COVID-19 Vaccine

COVID-19: Therapeutics, Preventives and Industry Perspectives

The FDA Calls for Pausing the Use of the Johnson & Johnson COVID-19 Vaccine

Oxford–AstraZeneca COVID-19 Vaccine: Regulators Give Update on Links to Rare Clotting Disorders

New Survey Highlights Public Support for Donation of COVID-19 Vaccines to Low-Income Countries

Clinical Trial To Explore Allergic Reactions to Moderna, Pfizer–BioNTech COVID-19 Vaccines Begins

The Long Run: Keeping an Eye on COVID-19 Vaccines

Moderna COVID-19 Vaccine Rollout Commences in the UK

Clinical Trial Evaluating COVID-19 Variant Vaccine Begins

Time-Temperature Indicator Could Monitor the Storage Conditions of mRNA Vaccines

New Data Suggests UK’s COVID-19 Vaccination Program Has Prevented Thousands of Elderly Deaths

Vaccine Passports: More Problematic Than Useful?

Will COVID-19 Vaccines Need To Be Evaluated and Adapted Regularly?

Why Do COVID-19 Vaccines Cause Side Effects?

How Do the Leading COVID-19 Vaccines Work?

Real-World Data Shows Benefit of Early Vaccination on Health Care Workforce

Oxford⁠–AstraZeneca Vaccine Is Safe and Highly Effective, Phase III Study Finds

Oxford–AstraZeneca Vaccine Not Associated With Overall Risk of Thromboembolic Events, Says EMA

New Study Provides Global Analysis of COVID-19 Vaccines

Oxford–AstraZeneca COVID-19 Vaccination Pause: What's the Story?

Novavax Announces COVID-19 Vaccine Has High Efficacy Against SARS-CoV-2 and Variant Strains

Harnessing Measles Vaccine’s Successful History To Protect Against SARS-CoV-2

Single Dose of Pfizer or Oxford Vaccine May Significantly Reduce Risk of Elderly COVID-19 Hospitalizations

New Study Predicts SARS-CoV-2 Evolving To Escape Current Vaccines

SARS-CoV-2 Variants Can Evade Antibodies That Neutralize Original Virus

The COVID-19 Whack-a-Mole

A New Nanotechnology-Based COVID-19 Vaccine Candidate

Data Shows Pfizer-BioNTech COVID-19 Vaccine Provides Protection From First Dose

Pfizer COVID-19 Vaccine Provokes Immune Response in Those Previously Infected

WHO Says Oxford’s Vaccine Is Safe and Likely to Be Efficacious in Older Adult

First-of-its-Kind Study Will Test Combination of Different COVID-19 Vaccines

Over 10 Million People Receive First Dose of COVID-19 Vaccine in UK

Different Types of COVID-19 Vaccines With Dr Seth Lederman

New Platform Can Quickly Make Vaccines at the Point-of-Care





















-Sinovac COVID-19 Vaccine Collaboration Receives Approval for Phase III Trial

-Optimizing the Discovery of Synthetic Antibodies for SARS-CoV-2

-Controlled Human Infection Models for SARS-CoV-2 Vaccine Development

-13 COVID-19 Vaccines Are in Human Clinical Trials – What Are They?

-Scientists Suggest That Childhood Vaccines Could Protect Against COVID-19

-First Volunteer Receives Imperial COVID-19 Vaccine

-Vaccine Against COVID-19 Advances to Late-stage Development

-GSK and Clover Biopharmaceuticals COVID-19 Vaccine Begins Human Clinical Trials

-Researchers Propose a Clinical Trial To Test MMR Vaccine for COVID-19

-Cobra Signs Supply Agreement with AstraZeneca for Manufacture of COVID-19 Vaccine Candidate

-Novavax Awarded Department of Defense Contract for COVID-19 Vaccine

-Industry Leaders Provide An Update on COVID-19 Vaccine Progress

-Oral Vaccine for COVID-19 On Track Towards Human Clinical Trials

-Phase I/II Clinical Trial of COVID-19 Vaccine Begins

-Positive Interim Phase 1 Data for mRNA Vaccine Against SARS-CoV-2

-Funding Boost for UK Vaccine Programme

-Analysis of SARS-CoV-2 Immune Response Bodes Well for Vaccine Development

-CEPI Extends Collaboration With Novavax To Advance Development and Manufacture of COVID-19 Vaccine

-Key Challenges in COVID-19 Vaccine Development Outlined

-Scientists Team Up To Create A Strategic Plan for COVID-19 Vaccine R&D

-Custom Lentivirus Pseudotyped with Spike Glycoprotein from SARS-CoV-2

-Positive Pre-clinical Data for Oral COVID-19 Vaccine Program

-SARS-CoV-2 Antibody Screening Trials To Aid Quest for Vaccine

-Novel Gene-based Vaccine Candidate Against SARS-CoV-2 in Development

-CEPI Announces a Ninth COVID-19 Vaccine Development Partnership

-Phase 1 U.S. Trial of COVID-19 DNA Vaccine Enrollment Complete

-Meet the Subjects of the UK's First Coronavirus Vaccine Clinical Trial

-Inside the UK's Coronavirus Vaccine Clinical Trial

-University of Oxford Partners With AstraZeneca To Accelerate Globalization of COVID-19 Vaccine in Clinical Trials

-New Partnership To Develop a Pan-Coronavirus DNA Vaccine

-MERS Vaccine Clinical Trial Offers Useful Insights for SARS-CoV-2 Vaccine Development

-First New Oral Polio Vaccine in 50 Years Offers Lessons for COVID-19

-UK Human Clinical Trials of COVID-19 Vaccine Set To Begin

-Preprint Suggests MERS-CoV Vaccine Can Protect Monkeys

-Consortium Members Work To Deliver UK's First COVID-19 Vaccine As Quickly and Safely As Possible

CEPI Grants Funding to INOVIO for Phase I/II Trial of COVID-19 Vaccine

Collaboration To Develop Gene-encoded Antibody Vaccine Against COVID-19 Is Underway



Meet The Authors
Laura Elizabeth Lansdowne
Laura Elizabeth Lansdowne
Managing Editor
Molly Campbell
Molly Campbell
Science Writer
Advertisement